Loading people...
Hugo Eliki-Roman is a venture capital professional based in an undisclosed location, currently serving as a Senior Analyst at Breega, a prominent early-stage investment firm operating across Europe and Africa. In his analytical capacity, he focuses on sourcing, evaluating, and supporting emerging technology startups for a European venture capital fund that manages more than €500 million in total assets. His organization maintains a primary operational presence in major European technology hubs, specifically the major cities of Paris, London, and Barcelona. He conducts comprehensive investment analysis, financial modeling, and market research to support the firm's core thesis of backing early-stage technology founders throughout the broader European and African startup ecosystems. Eliki-Roman's current professional focus centers entirely on identifying high-growth technology opportunities and providing rigorous analytical support for early-stage venture capital deployment across these emerging international markets.
Hugo Eliki-Roman is a key member of the investment team at Breega, a leading pan-European venture capital firm known for its founder-friendly approach and hands-on support. As an Analyst, Hugo plays a crucial role in the firm's mission to identify, evaluate, and back the next generation of European tech champions. His work is fundamental to Breega's investment process, from initial market research and deal sourcing to comprehensive due diligence and portfolio support.
At Breega, Hugo's responsibilities involve deep dives into emerging technological trends and market landscapes. He actively seeks out innovative startups that align with Breega's investment thesis, which typically spans a wide array of sectors including B2B SaaS, fintech, healthtech, deep tech, and consumer platforms. His analytical skills are vital in assessing the potential of prospective portfolio companies, examining their business models, market fit, team strength, and growth trajectories. This rigorous evaluation ensures that Breega continues to invest in companies poised for significant impact and scale.
While specific individual investments are typically attributed to the broader Breega investment committee, Hugo's contributions are integral to the firm's overall portfolio development. He works closely with partners and principals, providing critical insights that inform investment decisions and help shape Breega's strategic direction. His dedication helps Breega maintain its reputation for identifying high-potential ventures early in their lifecycle.
Hugo's career background likely reflects a strong foundation in finance, technology, or entrepreneurship, equipping him with the analytical rigor and industry understanding necessary for venture capital. Individuals in his role often bring experience from investment banking, consulting, or even direct startup operations, providing a multifaceted perspective on the challenges and opportunities faced by early-stage companies. This diverse background enables him to connect with founders and understand their vision from multiple angles.
Breega is committed to providing more than just capital; it offers operational expertise, talent acquisition support, and access to a vast network. Hugo's role as an Analyst contributes to this holistic support system, ensuring that portfolio companies receive the resources they need to thrive. His work helps reinforce Breega's position as a preferred partner for ambitious founders across Europe, driving innovation and economic growth within the tech ecosystem.
Hugo Eliki-Roman is an Analyst at Breega, a prominent European venture capital firm. He is involved in identifying and evaluating early-stage technology companies for investment.
As part of the Breega investment team, Hugo Eliki-Roman supports investments in a wide range of early-stage technology sectors, including B2B SaaS, fintech, healthtech, deep tech, and consumer platforms.
Hugo Eliki-Roman works at Breega, a leading pan-European venture capital firm that invests in early-stage technology companies across Europe.